Impact of Simeprevir Versus Telaprevir Triple Therapy for Chronic Hcv Infection on Patient-Reported Outcomes in Prior Non-Responders to Peginterferon/Ribavirin Results from the Phase Iii Attain Study
Abstract
Authors
J. Scott C. Corbett L. Gilles G. Wan U. Sbarigia W. Jessner